FFCP PHASE1:Mm9::chr6:125431797..125431806,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr6:125431797..125431806,-|id=chr6:125431797..125431806,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,3.38e-13,9|ontology_enrichment_disease=DOID:0060100!2.59e-16!3;DOID:4045!2.59e-16!3;DOID:0050686!2.08e-08!6|ontology_enrichment_disease_v019_2=DOID:0060100,6.64e-38,3;DOID:4045,6.64e-38,3;DOID:0050686,2.11e-19,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.38e-13,9;UBERON:0002036,3.38e-13,9;UBERON:0002385,3.38e-13,9;UBERON:0000486,3.38e-13,9;UBERON:0007503,3.38e-13,9;UBERON:0001015,3.38e-13,9;UBERON:0002329,3.38e-13,9;UBERON:0003082,3.38e-13,9;UBERON:0003059,3.38e-13,9;UBERON:0007282,3.38e-13,9;UBERON:0004290,3.38e-13,9;UBERON:0009618,3.38e-13,9;UBERON:0000383,5.96e-12,10;UBERON:0007524,6.27e-11,11;UBERON:0003077,6.27e-11,11;UBERON:0007285,6.27e-11,11|phase1_expression=0,0,0,0,0,0,0,0,0.422366166455,0.234064526321993,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.76678467663217,8.5946887897618,3.14114246384279,21.7645650571475,7.5135003345429,3.39857247121808,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.19980546198682,0.254140454146129,0,0,0,0,0,0,0,0,0,0.252722758433675,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.51469581422943,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.340439605753788,0,0,0,0,0,0,0,0,0,0,0,0,0,0.119372344003136,0,0,0,0,0,0,0,0,0,0,0.139951452323658,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202725215290164,0,0,0,0,0,0,0,0,0,0,0,0.116876902181569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr6:125431797..125431806,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr6:125431797..125431806,- | |||
|description=CAGE_peak_at_chr6:125431797..125431806,- | |||
|id=chr6:125431797..125431806,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.38e-13,9 | |||
|ontology_enrichment_disease=DOID:0060100!2.59e-16!3;DOID:4045!2.59e-16!3;DOID:0050686!2.08e-08!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,6.64e-38,3;DOID:4045,6.64e-38,3;DOID:0050686,2.11e-19,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.38e-13,9;UBERON:0002036,3.38e-13,9;UBERON:0002385,3.38e-13,9;UBERON:0000486,3.38e-13,9;UBERON:0007503,3.38e-13,9;UBERON:0001015,3.38e-13,9;UBERON:0002329,3.38e-13,9;UBERON:0003082,3.38e-13,9;UBERON:0003059,3.38e-13,9;UBERON:0007282,3.38e-13,9;UBERON:0004290,3.38e-13,9;UBERON:0009618,3.38e-13,9;UBERON:0000383,5.96e-12,10;UBERON:0007524,6.27e-11,11;UBERON:0003077,6.27e-11,11;UBERON:0007285,6.27e-11,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0.422366166455,0.234064526321993,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.76678467663217,8.5946887897618,3.14114246384279,21.7645650571475,7.5135003345429,3.39857247121808,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.19980546198682,0.254140454146129,0,0,0,0,0,0,0,0,0,0.252722758433675,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.51469581422943,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.340439605753788,0,0,0,0,0,0,0,0,0,0,0,0,0,0.119372344003136,0,0,0,0,0,0,0,0,0,0,0.139951452323658,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202725215290164,0,0,0,0,0,0,0,0,0,0,0,0.116876902181569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr6:125431797..125431806,- | |||
}} |
Latest revision as of 04:31, 5 August 2015
Short description: | p@chr6:125431797..125431806, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr6:125431797..125431806, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.38e-13 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.38e-13 | 9 |
striated muscle tissue | 3.38e-13 | 9 |
muscle tissue | 3.38e-13 | 9 |
multilaminar epithelium | 3.38e-13 | 9 |
epithelial vesicle | 3.38e-13 | 9 |
musculature | 3.38e-13 | 9 |
somite | 3.38e-13 | 9 |
myotome | 3.38e-13 | 9 |
presomitic mesoderm | 3.38e-13 | 9 |
presumptive segmental plate | 3.38e-13 | 9 |
dermomyotome | 3.38e-13 | 9 |
trunk paraxial mesoderm | 3.38e-13 | 9 |
musculature of body | 5.96e-12 | 10 |
dense mesenchyme tissue | 6.27e-11 | 11 |
paraxial mesoderm | 6.27e-11 | 11 |
presumptive paraxial mesoderm | 6.27e-11 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 6.64e-38 | 3 |
muscle cancer | 6.64e-38 | 3 |
organ system cancer | 2.11e-19 | 6 |